Director, Financial Planning & Analysis (FP&A)

Superluminal Medicines • Boston, Massachusetts • Full Time

Posted on Sun, Jul 19, 2026

About Superluminal Medicines:

Superluminal Medicines is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. We are expanding the team of talented scientists who seek to build the future of small molecule drug discovery with creativity and innovation.

Position Summary

We are seeking an experienced and strategic Director of Financial Planning & Analysis (FP&A) to build and lead FP&A capabilities for a growing clinical-stage biotechnology company. This role will serve as a key finance partner to executive leadership and cross-functional teams, providing insights that support strategic decision-making, resource allocation, and long-term growth.

The Director, FP&A will own financial planning, forecasting, business modeling, and performance analysis, with a focus on translating complex clinical development programs into actionable financial insights. This individual will partner closely with Research & Development, Clinical Operations, Corporate Operations, and Finance leadership to evaluate investment decisions, optimize resource allocation, and provide visibility into financial performance and future opportunities.

The ideal candidate will be a collaborative business partner who builds strong relationships across the organization, particularly with scientific and clinical teams. This individual will help translate complex financial concepts into meaningful insights, allowing our scientists and operators to focus on advancing our programs while ensuring they have the financial visibility and support needed to make informed decisions.

This is a highly visible role for a finance leader who enjoys building processes, developing scalable models, and partnering with scientific and operational leaders in a dynamic biotech environment.

Who Would Love This Role?

A finance leader who enjoys operating at the intersection of science, strategy, and finance. Someone who is energized by building processes from the ground up, partnering with senior leaders, and helping a growing biotech company make thoughtful decisions about where and how to invest resources.

A natural relationship builder who enjoys working closely with scientists and operational teams, getting into the details of their programs, and helping translate complex financial concepts into meaningful insights. Someone who sees Finance as a service organization and takes pride in being a trusted business partner,  enabling our scientific teams to focus on advancing science while providing the financial perspective needed to make thoughtful decisions.

Key Responsibilities

Strategic Financial Planning & Business Modeling

Budgeting, Forecasting & Performance Management

Executive & Board-Level Reporting

Cross-Functional Partnership & Process Development

Team Leadership & Development

Minimum Qualifications

Preferred Qualifications

Benefits:

Superluminal offers a comprehensive benefits package that fully covers employees’ annual deductibles and monthly premiums for medical, dental, and vision insurance. The package also includes a 401(k) match program, a Massachusetts transportation subsidy, equity, unlimited paid time off, and both disability and life insurance.

Equal Opportunity Statement:

Superluminal Medicines is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status.

View the interactive listing →